YZR Capital invests in healthtech startups such as Munich startup Deepeye MedicalThe Munich-based VC's portfolio ranges from AI-based medicine and 3D data visualization in the operating room to booking platforms, covering a wide range of areas within the healthcare system. The focus is on companies that aim to increase the efficiency and transparency of healthcare systems, simplify healthy living, or enable continuous change for better healthcare.
The name YZR (pronounced "Waiser") is intended to represent a synthesis of the English "wise" and the "Isar" river, reflecting the expertise of the founders and their team as well as their roots in the Munich ecosystem. In addition to the growth fund, investors include Beiersdorf AG, Bertelsmann Investments, the European Investment Fund, and KfW Capital.
“The right signals in a challenging time”
The two YZR Capital founders comment on the current investment by the Growth Fund Germany, Markus Feuerecker and Reinhard Meier, as follows:
"The Growth Fund Germany is sending the right signals in challenging times and, thanks to its one billion euro volume, has the power to significantly improve the investment climate. Innovation drivers such as startups are driving technological development, which brings enormous benefits and significant social added value, especially in the healthcare sector."
The Growth Fund Germany was initiated by the German federal government and is financed by private and institutional investors. KfW Capital, one of the largest VC fund investors in Europe, acts as both investment broker and investment advisor for the Growth Fund Germany.
